Molecular targets for breast cancer therapy and prevention.
about
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblastsDecreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cellsBridging academic science and clinical research in the search for novel targeted anti-cancer agentsPutting tumours in contextCDA: combinatorial drug discovery using transcriptional response modulesAlpha cyano-4-hydroxy-3-methoxycinnamic acid inhibits proliferation and induces apoptosis in human breast cancer cellsConditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathyA pan-cancer analysis of prognostic genes.Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins.Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells.Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells.Initiating oncogenic event determines gene-expression patterns of human breast cancer modelsNegative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1.Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer.Characterization of aberrant pathways across human cancersOverexpression of Eag1 potassium channels in clinical tumours.Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma.Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration.Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1Arsenic trioxide induces the apoptosis of human breast cancer MCF-7 cells through activation of caspase-3 and inhibition of HERG channels.Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinomaDual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells.Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules.Toward the semisynthesis of multidomain transmembrane receptors: modification of Eph tyrosine kinases.Immunotherapeutic strategies to target prognostic and predictive markers of cancer.Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer.The molecular genetics of breast cancer and targeted therapyIn vivo cancer biomarkers of esophageal neoplasiaA perspective on challenges and issues in biomarker development and drug and biomarker codevelopment.The in vivo Therapeutic Effect of Free Wanderer Powder ( xiāo yáo sǎn, Xiaoyaosan) on Mice with 4T1 Cell Induced Breast Cancer Model.Emerging therapeutic targets in schwannomas and other merlin-deficient tumors.Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer.ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective.Personalized medicine policy challenges: measuring clinical utility at point of care.Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy.Somatic alterations as the basis for resistance to targeted therapies.Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.The role of Plk3 in oncogenesis.
P2860
Q24292464-C0BF0299-F02F-4D14-901B-EE0D071BD27BQ24798573-CBBDD7B2-1E10-44D0-8857-5D555FB83C01Q26771396-714E0451-3BCB-40B1-9427-3D85F9808C88Q28207789-D171AD44-75E8-401A-80FB-D67D7165B526Q28482122-0E7BB11F-EB9D-4F57-A593-720CC58ABFDBQ28536827-5B421C30-C736-4D7D-9D86-EF1B48E5E197Q28593656-BFA7F74E-B99E-40D6-B65D-11F748E1C4EDQ30301043-BAD6F772-B04E-4F75-8F40-41F150826701Q30882620-50B6DF47-0690-4C4B-93AC-EDB3EE8EA336Q33269602-423A599C-AC66-41A6-A94F-BB36EACFB3B0Q33980773-BF04F082-6E0B-4F54-B8C1-2358557679A4Q34068051-79A357D8-F9B5-4852-BCC0-6017A8112F37Q34281830-202C7B45-5951-49F9-9E82-810EFF020597Q34675534-F5F5421A-9F9F-43EF-B7CB-3715342F64C2Q35051387-FD6694CD-8D21-4603-BB12-68722D1F658AQ35107467-F47F659A-26F0-4171-B0CF-2D9BFAA2F0A3Q35624010-8AFF1C22-502E-4165-878E-16E2986B40F9Q36079202-19C49B1F-7F7B-453E-8F8E-F9B72395A0CFQ36109632-77EAB82E-FB26-452D-A8E2-93B6B6175ECAQ36114852-0D074A50-747A-43E2-95BF-EB011CAC267EQ36117441-3111655D-A0D5-4E57-B0DC-E6BE11154CA7Q36230637-B87DDF4A-F202-48EC-8E10-735051646F96Q36324624-9ED057B8-8EDE-43E7-A941-BB9E70F0AE3AQ36626059-48D91FC4-A672-43AF-BBE8-0DC18639634DQ36758884-0A6B17CB-3041-4E87-A926-6E9121546A2FQ36901612-1D76D389-39A1-4F94-AE5C-15D4483D2BE3Q37126006-2424D334-8439-4960-80AD-0B82EDE52BF0Q37288668-1F8258AA-77ED-4A4D-95A2-30BA2313344EQ37290512-0A135BB2-3840-41E4-9B45-5D813172F3E4Q37363691-7C06C20A-BB88-4451-84FC-1B5B85FCE55EQ37411548-DA429B9C-91DC-4389-934C-FC3551D95EABQ37618376-1D5B4759-9B17-49F1-BD14-25AC5FCE4C9DQ37885731-1C2864AC-D428-4EDD-9FAB-FA23BE7CD21EQ37962472-3855CC5B-4EF8-4D88-96DE-467288FC1B27Q37970020-8F9CFCF3-5840-4BA1-90EE-7A80643DF201Q38027568-962D0ADD-FA22-4D15-BEF1-A57A95977FB2Q38033672-D124FF4A-D488-4189-BE9C-1EBA90F7042EQ38151570-7FCEBE1B-579B-439A-87F3-5E4DB98AD813Q38336801-67E780CE-1C33-4015-8231-8C51C3A60CF3Q38444150-AD2008E3-2CA7-434B-A3B7-185075EE2D6C
P2860
Molecular targets for breast cancer therapy and prevention.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Molecular targets for breast cancer therapy and prevention.
@ast
Molecular targets for breast cancer therapy and prevention.
@en
type
label
Molecular targets for breast cancer therapy and prevention.
@ast
Molecular targets for breast cancer therapy and prevention.
@en
prefLabel
Molecular targets for breast cancer therapy and prevention.
@ast
Molecular targets for breast cancer therapy and prevention.
@en
P2093
P356
P1433
P1476
Molecular targets for breast cancer therapy and prevention.
@en
P2093
P2888
P304
P356
10.1038/87872
P407
P577
2001-05-01T00:00:00Z